Ceftobiprole - Injectable Anti-MRSA Cephalosporin Antibiotic


Ceftobiprole medocaril (BAL5788) is the product of a joint development programme between Basilea Pharmaceutica AG and Cilag AG International (a Johnson & Johnson company).

  • Ceftobiprole medocaril
  • Soft tissue infections
  • Basilea Pharmaceutica
  • Ceftobiprole Medocaril
  • Infections in hospitalised patients
  • Ceftobiprole has been approved


| 1 | 2 | 3 | 4 | 5 | 6 |

Browse More Images - Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development